Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation

Sustained challenges faced by clinical teams on the frontline of an NHS under pressure are well documented in daily headlines.
CEM is an innovative highly sensitive and low-cost breast imaging modality which combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.